This document is an excerpt from the EUR-Lex website
Document 62021TA0194
Case T-194/21: Judgment of the General Court of 21 December 2021 — Fidia farmaceutici v EUIPO — Stelis Biopharma (HYALOSTEL ONE) (EU trade mark — Opposition proceedings — International figurative registration designating the European Union — Figurative mark HYALOSTEL ONE — Earlier EU word mark HYALISTIL and earlier figurative mark HyalOne — Earlier international word mark HYALO — Relative ground for refusal — Article 8(1)(b) of Regulation (EU) 2017/1001 — Obligation to state reasons)
Cás T-194/21: Breithiúnas na Cúirte Ginearálta an 21 Nollaig 2021 – Fidia farmaceutici v EUIPO – Stelis Biopharma (HYALOSTEL ONE)
Cás T-194/21: Breithiúnas na Cúirte Ginearálta an 21 Nollaig 2021 – Fidia farmaceutici v EUIPO – Stelis Biopharma (HYALOSTEL ONE)
IO C 95, 28.2.2022, p. 33–33
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
IO C 95, 28.2.2022, p. 11–11
(GA)
28.2.2022 |
GA |
Iris Oifigiúil an Aontais Eorpaigh |
C 95/11 |
Breithiúnas na Cúirte Ginearálta an 21 Nollaig 2021 – Fidia farmaceutici v EUIPO – Stelis Biopharma (HYALOSTEL ONE)
(Cás T-194/21)
(2022/C 95/45)
Teanga an cháis: an Béarla
Níl san Iris Oifigiúil seo ach na fógraí maidir le cásanna ar cuireadh clabhsúr leo roimh an 1 Eanáir 2022 agus mar sin níl leagan Gaeilge ar fáil.